Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong · Delayed Price · Currency is HKD 0.1750
-0.0080 (-4.37%)
Jan 21, 2026, 3:37 PM HKT
HKG:6833 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 42.56 | 42.05 | 42.35 | 69.46 | 135.08 | 118.14 | Upgrade |
Depreciation & Amortization | 29.01 | 24.42 | 16.32 | 11.36 | 6.68 | 9.4 | Upgrade |
Other Amortization | 0.08 | 0.08 | 0 | - | 0.02 | 0.02 | Upgrade |
Loss (Gain) From Sale of Assets | -0.67 | 1.14 | -0.04 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | -0.28 | -0.16 | 0.05 | Upgrade |
Provision & Write-off of Bad Debts | 2.85 | -3.92 | 4.25 | 6.21 | 1.02 | -0.35 | Upgrade |
Other Operating Activities | 18.68 | 28.64 | 45.97 | -5.97 | 22.5 | 14.69 | Upgrade |
Change in Accounts Receivable | -37.72 | -71.98 | -195.89 | -133.87 | 364.07 | -547.63 | Upgrade |
Change in Inventory | -229.84 | -244.31 | -19.88 | -26.88 | 181.29 | 13.46 | Upgrade |
Change in Accounts Payable | 241.49 | 55.39 | 444.18 | -21.2 | -277.39 | 399.85 | Upgrade |
Change in Unearned Revenue | -15.79 | -12.73 | -34.97 | 47.68 | -0.06 | -10.78 | Upgrade |
Change in Other Net Operating Assets | -28.79 | -51.65 | 51.41 | 128.57 | -127.34 | 140.44 | Upgrade |
Operating Cash Flow | 21.86 | -232.88 | 353.7 | 75.08 | 305.71 | 137.3 | Upgrade |
Operating Cash Flow Growth | - | - | 371.09% | -75.44% | 122.66% | - | Upgrade |
Capital Expenditures | -26.32 | -35.16 | -29.55 | -52.69 | -23.52 | -0.37 | Upgrade |
Sale of Property, Plant & Equipment | 0.07 | - | 0.91 | 0.3 | - | - | Upgrade |
Cash Acquisitions | - | - | - | -68 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -21.18 | -17.92 | -15.11 | - | - | - | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | - | - | -49.11 | Upgrade |
Investment in Securities | - | - | - | - | - | 1.99 | Upgrade |
Other Investing Activities | 2.95 | 0.21 | -19.87 | 1.12 | 0.8 | 0.65 | Upgrade |
Investing Cash Flow | -44.48 | -52.87 | -63.63 | -119.27 | -22.73 | -46.84 | Upgrade |
Long-Term Debt Issued | - | 361.1 | 180.02 | 180 | 210 | 120.33 | Upgrade |
Total Debt Issued | 295.47 | 361.1 | 180.02 | 180 | 210 | 120.33 | Upgrade |
Long-Term Debt Repaid | - | -306.34 | -123.97 | -341.45 | -78.66 | -227.3 | Upgrade |
Total Debt Repaid | -446.19 | -306.34 | -123.97 | -341.45 | -78.66 | -227.3 | Upgrade |
Net Debt Issued (Repaid) | -150.72 | 54.76 | 56.05 | -161.45 | 131.34 | -106.97 | Upgrade |
Issuance of Common Stock | - | - | - | 159.46 | 75.37 | - | Upgrade |
Common Dividends Paid | -3.67 | -7.22 | -18.11 | - | - | - | Upgrade |
Other Financing Activities | 135.34 | 107.05 | -227.66 | 37.03 | -303.83 | -62.9 | Upgrade |
Financing Cash Flow | -19.05 | 154.59 | -189.73 | 35.04 | -97.11 | -169.88 | Upgrade |
Foreign Exchange Rate Adjustments | -7.71 | 1.56 | 8.43 | 12.24 | -3.59 | -1.57 | Upgrade |
Net Cash Flow | -49.38 | -129.6 | 108.78 | 3.09 | 182.29 | -80.99 | Upgrade |
Free Cash Flow | -4.46 | -268.04 | 324.15 | 22.39 | 282.19 | 136.93 | Upgrade |
Free Cash Flow Growth | - | - | 1347.74% | -92.07% | 106.09% | - | Upgrade |
Free Cash Flow Margin | -0.18% | -9.50% | 12.76% | 0.99% | 13.94% | 6.68% | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.13 | 0.16 | 0.01 | 0.16 | 0.08 | Upgrade |
Cash Interest Paid | 20.26 | 16.64 | 14.43 | 18.33 | 22.47 | 6.87 | Upgrade |
Cash Income Tax Paid | 41.05 | 62.2 | 37.37 | 39.66 | 41.69 | 7.11 | Upgrade |
Levered Free Cash Flow | 94.67 | -175.42 | 111.78 | 57.81 | -85.98 | 81.61 | Upgrade |
Unlevered Free Cash Flow | 104.68 | -167.57 | 117.91 | 66.44 | -72.58 | 85.9 | Upgrade |
Change in Working Capital | -70.65 | -325.27 | 244.85 | -5.7 | 140.57 | -4.65 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.